PolyMedix, Inc.

Location:PA, US
Speaker:Dawn Eringis
Title:VP Business Development
Primary Industry:Health & Medical Devices
Executive Summary:PolyMedix develops biomimetics- novel small molecules and polymers which mimic the activity of proteins. Our first program is designing antiobiotic drugs and antimicrobial materials that mimic the activity of host defense proteins, and for which bacterial resistance is HIGHLY UNLIKELY to develop. The lead compounds are potent and broad spectrum, active against over 300 gram-positive and gram-negative strains of human pathogens. They are active against drug-resistant bacteria and rapidly cidal (within minutes). In addition, our compounds are highly selective for bacterial versus mammalian cells. The polymers have been successfully incorporated into various plastics, coatings and formulations and retain their antimicrobial activity. PolyMedix\'s compounds are relatively easy and cheap to synthesize. Importantly, our compounds\' unique mechanism of action means it will be extremely difficult for bacteria to develop resistance. PolyMedix will outlicense all of the antimicrobial polymer materials uses of our compounds. We will retain US rights to the I.V. antibiotics and outlicense overseas rights.
Venture is:Public

HIGHLIGHTS

Corporate Presentations:

  • Air Products
  • BASF
  • Eastman Kodak Company
  • Genzyme
  • Goodrich
  • Hewlett-Packard
  • Honda
  • Medtronic
  • Merck
  • Sanyo

Reserved Presentations:

  • ExxonMobil
  • IBM

Partnering Events:
(full access included)

Platinum Sponsor

University of Hawaii

Press Sponsor

Business Wire

Commercialization Partner

BusinessWeek

Sponsors

Invest Australia AzTE Technology Enterprises

Media Sponsors

(joint with Nanotech 2007) Nature
Science
Red Herring

Supporting Organizations

BirchBob
CONNECT
Boston University
Midwest Research University Network
OCTANe
AeA
LES-SVC

 

“A major challenge for both the technology and the financial communities is finding a forum in which all parties can interact and explore possibilities for future innovation. TechConnect was created to fill this void, bringing both sides together under one roof into a setting that ultimately will help significant ground-breaking concepts come to life.”
 
Matthew Laudon, Co-Founder and Director of TechConnect